A preoperative prognostic score for resected pancreatic and periampullary neuroendocrine tumours

Pancreatology

Volumn 9, Issue 5, 2009, Pages 670-676

  Sakka, Nicole ^a   Smith, Richard A ^a   Whelan, Philip ^a   Ghaneh, Paula ^a   Sutton, Robert ^a   Raraty, Michael ^a   Campbell, Fiona ^b   Neoptolemos, John P ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Neuroendocrine tumour, periampullary pancreatic; Prognostic factors, neuroendocrine tumours; Resection, tumour

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ADVERSE OUTCOME; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANALYTICAL PARAMETERS; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; DATA BASE; DIAGNOSTIC VALUE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; LYMPHOCYTE; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; OVERALL SURVIVAL; PANCREAS RESECTION; PANCREAS TUMOR; PERIAMPULLARY NEUROENDOCRINE TUMOR; POPULATION RISK; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SIPPLE SYNDROME; SURGICAL MORTALITY; SURVIVAL TIME; THROMBOCYTE; TISSUE SECTION; TUMOR DIFFERENTIATION; TUMOR VOLUME;

EID: 68549107889     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000181179     Document Type: Article

References (25)

1. Fesinmeyer MD, Austin MA, Li CI, De Roos AJ, Bowen DJ: Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 1766-1773.
2. Alexakis N, Neoptolemos JP: Pancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol 2008; 22: 183-205.
3. Alexakis N, Connor S, Ghaneh P, Lombard M, Smart HL, Evans J, Hughes M, Garvey CJ, Vora J, Vinjamuri S, Sutton R, Neoptolemos JP: Hereditary pancreatic endocrine tumours. Pancreatology 2004; 4: 417-433.
4. Jarufe NP, Coldham C, Orug T, Mayer AD, Mirza DF, Buckels JA, Bramhall SR: Neuroendocrine tumours of the pancreas: predictors of survival after surgical treatment. Dig Surg 2005; 22: 157-162.
5. Oberg K, Eriksson B: Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol 2005; 19: 753-781.
6. Vagefi, Razo O, Deshpande V, McGrath DJ, Lauwers GY, Thayer SP, Warshaw AL, Fernandez- Del Castillo C: Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms. Arch Surg 2007; 142: 347-354.
7. Phan GQ, Yeo CJ, Hruban RH, Lillemoe KD, Pitt HA, Cameron JL: Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg 1998; 2: 472-482.
8. Solorzano CC, Lee JE, Pisters PW, Vauthey JN, Ayers GD, Jean ME, Gagel RF, Ajani JA, Wolff RA, Evans DB: Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery 2001; 130: 1078-1085.
9. Gullo L, Miglori M, Falconi M, Pederzoli P, Bettini R, Casadei R, Delle Fave G, Corleto VD, Ceccarelli C, Santini D, Tomassetti P: Nonfunctioning pancreatic endocrine tumours: a multicenter clinical study. Am J Gastroenterol 2003; 98: 2435-2439.
10. Hochwald SN, Zee S, Conlon KC, Colleoni R, Louie O, Brennan MF, Klimstra DS: Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate grade groups. J Clin Oncol 2002; 20: 2633-2642.
11. Fendrich V, Langer P, Celik I, Bartsch DK, Zielke A, Ramaswamy A, Rothmund M: An aggressive surgical approach leads to longterm survival in patients with pancreatic endocrine tumours. Ann Surg 2006; 244: 845-853.
12. Brown KM, Domin C, Aranha GV, Yong S, Shoup M: Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas. Am J Surg 2005; 189: 278-282.
13. Fogar P, Sperti C, Basso D, Sanzari MC, Greco E, Davoli C, Navaglia F, Zambon CF, Pasquali C, Venza E, Pedrazzoli S, Plebani M: Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas 2006; 32: 22-28.
14. Jamieson NB, Glen P, McMillan DC, McKay CJ, Foulis AK, Carter R, Imrie CW: Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer 2005; 92: 21-23.
15. Capella C, Heitz PU, Hofler H, Solcia E, Kloppel G: Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 1995; 425: 547-560.
16. Kloppel G, Perren A, Heitz PU: The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification system. Ann NY Acad Sci 2004; 1014: 13-27.
17. Altman DG, Lausen B, Sauerbrei W, Schumacher M: Dangers of using optimal cutpoints in the evaluation of prognostic factors. J Nat Cancer Inst 1994; 86: 829-835.
18. Vittinghoff E, McCulloch CE: Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 2007; 165: 710-718.
19. Bilimoria KY, Talamonti MS, Tomlinson JS, Stewart AK, Winchester DP, Ko CY, Bentrem DJ: Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3,851 patients. Ann Surg 2008; 247: 490-500.
20. Nguyen SQ, Angel LP, Divino CM, Schluender S, Warner RR: Surgery in malignant pancreatic neuroendocrine tumours. J Surg Oncol 2007; 96: 397-403.
21. Kazanjian KK, Reber HA, Hines OJ: Resection of pancreatic neuroendocrine tumors: results of 70 cases. Arch Surg 2006; 141: 765-770.
22. Glen P, Jamieson NB, McMillan DC, Carter R, Imrie CW, McKay CJ: Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. Pancreatology 2006; 6: 450-453.
23. Lien YC, Hsieh CC, Wu YC, Hsu HS, Hsu WH, Wang LS, Huang MH, Huang BS: Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia. J Gastrointest Surg 2004; 8: 1041-1048.
24. Clancy TE, Sengupta TP, Paulus J, Ahmed F, Duh MS, Kulke MH: Alkaline phosphatase predicts survival in patients with metastatic neuroendocrine tumors. Dig Dis Sci 2006; 51: 877-884.
25. Smith RA, Bosonnet L, Raraty M, Sutton R, Neoptolemos JP, Campbell F, Ghaneh P: Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg 2008; Epub ahead of print.